Willemijn Scholten

20132018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2018

  • 5 Article
  • 1 Meeting Abstract
  • 1 Comment/Letter to the editor
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Zeijlemaker, W., Grob, T., Meijer, R., Hanekamp, D., Kelder, A., Carbaat-Ham, J. C., Oussoren-Brockhoff, Y. J. M., Snel, A. N., Veldhuizen, D., Scholten, W. J., Maertens, J., Breems, D. A., Pabst, T., Manz, M. G., van der Velden, V. H. J., Slomp, J., Preijers, F., Cloos, J., van de Loosdrecht, A. A., Löwenberg, B. & 4 othersValk, P. J. M., Jongen-Lavrencic, M., Ossenkoppele, G. J. & Schuurhuis, G. J., 2018, In : Leukemia.

Research output: Contribution to journalArticleAcademicpeer-review

LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

Zeijlemaker, W., Meijer, R., Kelder, A., Carbaat-Ham, J., Oussoren-brockhoff, Y., Snel, S., Veldhuizen, D., Scholten, W., Maertens, J., Breems, D., Pabst, T., Manz, M., Van der Velden, V., Slomp, J., Valk, P., Cloos, J., Lowenberg, B., Ossenkoppele, G. & Schuurhuis, G. J., 26 Jun 2017, In : Haematologica. 102, p. 7-8

Research output: Contribution to journalMeeting AbstractAcademic

Activities 2018 2018

  • 1 Invited talk

Langdurig gebruik van antidepressiva bij angststoornissen

Neeltje Batelaan (Speaker), WD Scholten (Speaker)
Sep 2018

Activity: Talk or presentationInvited talk

Press / Media

Van angst naar beter

Neeltje Batelaan, Ton van Balkom & Willemijn Scholten

24/10/2018

1 media contribution

Press/Media: Other